{"id":"W4244139576","doi":"10.1200/jco.2004.22.90140.5019","title":"Phase II study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer: NCIC CTG IND-148","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Erlotinib; Rash; Internal medicine; Toxicity; Gastroenterology; Neutropenia; Chemotherapy; Erlotinib Hydrochloride; Oncology; Cancer; Surgery; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001218229,0.001224734,0.00124299,0.0004143364,0.0003378399,0.0004170439,0.0008621086,0.001196241,0.004190152],"category_scores_gemma":[0.0005886343,0.0004685375,0.0005958368,0.0003810648,0.0005268028,0.0003184006,0.0003126137,0.001663102,0.0009551024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008028081,"about_ca_system_score_gemma":0.001590276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002144606,"about_ca_topic_score_gemma":0.005845617,"domain_scores_codex":[0.9997368,0.0001318455,0.00001203342,0.00003171675,0.00002880763,0.00005865015],"domain_scores_gemma":[0.9996563,0.0000557953,0.00005437286,0.00002283469,0.00002266159,0.0001880461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5754598,0.1066544,0.03118945,0.002004194,0.001357612,0.001708159,0.0006708486,0.004640595,0.08350223,0.0003848735,0.01373891,0.1786889],"study_design_scores_gemma":[0.4173899,0.5337032,0.03444525,0.00007338005,0.0004036881,0.000928044,0.0001028194,0.001453945,0.004126847,0.0001392798,0.007200129,0.0000335836],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890898,0.002067346,0.0003612041,0.0005270354,0.00006265667,0.003994906,0.001633272,0.00006904537,0.002194886],"genre_scores_gemma":[0.9779606,0.002516887,0.001894666,0.001485453,0.0001281181,0.005342787,0.005377396,0.00003352774,0.005260488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004190152,"threshold_uncertainty_score":0.01401746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1604161750413085,"score_gpt":0.5595969058124701,"score_spread":0.3991807307711616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}